Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Steven Rosenberg

Concepts (595)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
57
2025
324
13.650
 Why?
Lymphocytes, Tumor-Infiltrating
62
2025
218
13.360
 Why?
Receptors, Antigen, T-Cell
55
2024
727
10.650
 Why?
Immunotherapy, Adoptive
53
2024
380
9.820
 Why?
T-Lymphocytes
47
2024
2036
7.020
 Why?
Melanoma
49
2024
808
6.860
 Why?
Neoplasms
35
2025
2809
5.070
 Why?
Gastrointestinal Neoplasms
8
2025
75
4.350
 Why?
CD8-Positive T-Lymphocytes
26
2023
928
3.730
 Why?
Autism Spectrum Disorder
22
2024
427
3.360
 Why?
Immunotherapy
16
2025
659
3.030
 Why?
Adoptive Transfer
18
2024
219
2.660
 Why?
Proto-Oncogene Proteins p21(ras)
8
2022
260
2.590
 Why?
Developmental Disabilities
13
2023
292
2.320
 Why?
Mutation
32
2025
4059
2.320
 Why?
Cancer Vaccines
8
2021
167
2.050
 Why?
Antigens, CD19
9
2022
140
1.960
 Why?
Programmed Cell Death 1 Receptor
9
2025
263
1.870
 Why?
CD4-Positive T-Lymphocytes
12
2022
1130
1.850
 Why?
Interleukin-2
7
2025
451
1.780
 Why?
Skin Neoplasms
13
2020
869
1.770
 Why?
Neoplasm Metastasis
18
2024
682
1.730
 Why?
Autistic Disorder
8
2024
213
1.670
 Why?
Humans
194
2025
143807
1.450
 Why?
ras Proteins
4
2021
148
1.390
 Why?
Colorectal Neoplasms
5
2025
834
1.310
 Why?
Neoplasm Proteins
7
2019
443
1.280
 Why?
Tumor Suppressor Protein p53
6
2022
539
1.230
 Why?
High-Throughput Nucleotide Sequencing
6
2025
551
1.210
 Why?
Epitopes, T-Lymphocyte
9
2021
184
1.160
 Why?
Eligibility Determination
3
2014
70
1.160
 Why?
Genetic Therapy
8
2022
320
1.110
 Why?
Lymphoma, B-Cell
4
2020
133
1.050
 Why?
Membrane Proteins
9
2019
1177
1.040
 Why?
Female
101
2025
77403
1.000
 Why?
Glioblastoma
2
2021
351
0.990
 Why?
Proto-Oncogene Proteins B-raf
4
2019
230
0.980
 Why?
Motor Skills Disorders
4
2016
29
0.970
 Why?
Child Development
7
2024
507
0.900
 Why?
Male
86
2025
71658
0.860
 Why?
Genetic Engineering
6
2016
94
0.860
 Why?
Transcriptome
4
2022
1029
0.850
 Why?
HLA-A2 Antigen
11
2020
47
0.850
 Why?
Middle Aged
56
2025
35398
0.840
 Why?
Gene Expression Regulation, Neoplastic
7
2019
1489
0.800
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2017
190
0.800
 Why?
Cell Line, Tumor
26
2021
3615
0.800
 Why?
Coronary Artery Disease
6
2017
722
0.790
 Why?
Flow Cytometry
9
2018
1192
0.780
 Why?
Precision Medicine
3
2015
446
0.760
 Why?
T-Lymphocyte Subsets
5
2019
422
0.750
 Why?
Ovarian Neoplasms
2
2019
586
0.740
 Why?
Medicare Part C
2
2013
32
0.730
 Why?
Tumor Microenvironment
2
2019
733
0.720
 Why?
Cell Separation
4
2019
311
0.720
 Why?
Adult
46
2025
40083
0.690
 Why?
Single-Cell Analysis
3
2022
355
0.680
 Why?
HLA-DP beta-Chains
3
2019
90
0.680
 Why?
Interleukin-12
3
2020
124
0.670
 Why?
Receptors, Antigen
3
2015
17
0.660
 Why?
Cognition Disorders
2
2016
531
0.630
 Why?
HLA-A Antigens
2
2021
56
0.630
 Why?
Receptors, Antigen, T-Cell, alpha-beta
4
2020
335
0.630
 Why?
Hematopoietic Stem Cell Transplantation
3
2022
678
0.620
 Why?
Aged
35
2025
25356
0.620
 Why?
Antigen Presentation
8
2020
214
0.620
 Why?
Retroviridae
2
2022
104
0.610
 Why?
Mutation, Missense
2
2020
346
0.600
 Why?
Interleukin-15
2
2017
101
0.600
 Why?
Colonic Neoplasms
2
2019
259
0.600
 Why?
Mucin-4
1
2019
4
0.600
 Why?
Smad5 Protein
1
2019
8
0.590
 Why?
Temperament
1
2019
45
0.590
 Why?
Lymphocyte Depletion
2
2016
136
0.580
 Why?
Immunity, Cellular
1
2020
269
0.580
 Why?
Exome
7
2016
240
0.580
 Why?
T-Lymphocytes, Regulatory
2
2019
399
0.560
 Why?
Cholangiocarcinoma
2
2023
100
0.560
 Why?
Child, Preschool
29
2024
11772
0.560
 Why?
Sequence Analysis, DNA
2
2021
823
0.560
 Why?
Bile Duct Neoplasms
2
2023
121
0.550
 Why?
ErbB Receptors
2
2019
618
0.550
 Why?
Disease Susceptibility
1
2019
354
0.520
 Why?
Family Characteristics
2
2018
192
0.510
 Why?
Genetic Vectors
5
2022
342
0.510
 Why?
Antigens
1
2019
350
0.510
 Why?
History, 20th Century
4
2025
328
0.500
 Why?
Child Behavior
1
2019
253
0.500
 Why?
RNA, Messenger
3
2020
2854
0.500
 Why?
Social Behavior
2
2023
291
0.500
 Why?
History, 21st Century
3
2025
220
0.490
 Why?
Awards and Prizes
1
2017
72
0.480
 Why?
Myocardial Perfusion Imaging
2
2013
49
0.480
 Why?
Transposases
1
2016
19
0.480
 Why?
Cell Engineering
1
2016
15
0.480
 Why?
Communication
2
2023
956
0.470
 Why?
Gene Expression Profiling
8
2019
1794
0.460
 Why?
Bile Ducts, Intrahepatic
2
2023
61
0.460
 Why?
Self-Injurious Behavior
4
2018
141
0.460
 Why?
Lymphoma
1
2017
229
0.460
 Why?
Cell Cycle Checkpoints
1
2016
103
0.460
 Why?
Psychotherapy
1
2017
187
0.450
 Why?
Immunologic Memory
5
2024
365
0.450
 Why?
Surveys and Questionnaires
9
2024
6033
0.420
 Why?
T-Cell Antigen Receptor Specificity
7
2020
51
0.410
 Why?
Breast Neoplasms
3
2022
2321
0.410
 Why?
Lymphocyte Transfusion
1
2013
20
0.410
 Why?
Lymphocyte Activation
10
2020
1143
0.410
 Why?
Lymphocytes
1
2016
398
0.400
 Why?
Sentinel Lymph Node Biopsy
1
2014
115
0.400
 Why?
Th1 Cells
1
2014
140
0.400
 Why?
Vidarabine
4
2017
35
0.400
 Why?
Plaque, Atherosclerotic
1
2014
58
0.390
 Why?
Leukemia
2
2016
245
0.390
 Why?
Histocompatibility Antigens Class I
5
2021
208
0.390
 Why?
Lymph Node Excision
1
2014
170
0.390
 Why?
Transplantation Conditioning
4
2019
186
0.380
 Why?
Animals
29
2024
38066
0.380
 Why?
Indoles
1
2016
481
0.380
 Why?
Cyclophosphamide
4
2017
259
0.380
 Why?
Child
22
2024
22771
0.370
 Why?
Melanoma, Experimental
4
2020
111
0.370
 Why?
Cell- and Tissue-Based Therapy
3
2019
83
0.370
 Why?
Sulfonamides
1
2016
582
0.370
 Why?
Stem Cell Transplantation
1
2013
187
0.370
 Why?
Transfection
1
2014
950
0.360
 Why?
Gene Expression
7
2016
1505
0.360
 Why?
Genes, T-Cell Receptor
3
2022
9
0.360
 Why?
Mice
21
2024
18414
0.350
 Why?
Melanoma-Specific Antigens
3
2016
5
0.340
 Why?
Antibodies, Monoclonal
3
2017
1477
0.340
 Why?
Adaptor Proteins, Signal Transducing
1
2014
441
0.340
 Why?
Neoplasms, Second Primary
2
2022
99
0.330
 Why?
Coronary Angiography
5
2017
318
0.330
 Why?
Biomarkers, Tumor
6
2019
1285
0.330
 Why?
Case-Control Studies
13
2024
3633
0.330
 Why?
Coculture Techniques
3
2021
250
0.320
 Why?
Treatment Outcome
15
2021
11389
0.320
 Why?
Lung Neoplasms
3
2022
2582
0.320
 Why?
Transplantation, Autologous
3
2022
285
0.320
 Why?
United States
16
2025
15584
0.320
 Why?
Papillomaviridae
3
2019
121
0.310
 Why?
gp100 Melanoma Antigen
5
2016
8
0.310
 Why?
Medicaid
1
2014
460
0.310
 Why?
Child Development Disorders, Pervasive
2
2024
62
0.310
 Why?
Kidney Neoplasms
1
2014
407
0.310
 Why?
Infant
11
2017
10014
0.300
 Why?
Papillomavirus Infections
3
2018
369
0.300
 Why?
Transduction, Genetic
4
2019
135
0.290
 Why?
Combined Modality Therapy
5
2021
1254
0.290
 Why?
Human papillomavirus 16
3
2018
31
0.290
 Why?
Peptides
4
2020
981
0.280
 Why?
Phenotype
6
2024
3209
0.280
 Why?
Prospective Studies
8
2023
7915
0.270
 Why?
Repressor Proteins
3
2017
438
0.270
 Why?
Intellectual Disability
3
2024
178
0.270
 Why?
Antigens, Differentiation, T-Lymphocyte
2
2020
103
0.270
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
3
2017
27
0.260
 Why?
Cells, Cultured
8
2021
4183
0.260
 Why?
Prevalence
8
2018
2831
0.250
 Why?
Carcinoma, Squamous Cell
3
2017
648
0.250
 Why?
Algorithms
3
2015
1818
0.250
 Why?
Dendritic Cells
4
2019
503
0.250
 Why?
Neoplasm Staging
5
2018
1418
0.250
 Why?
Oncogene Proteins, Viral
2
2017
22
0.250
 Why?
Lymphocyte Count
2
2016
167
0.240
 Why?
Uterine Cervical Neoplasms
4
2018
272
0.240
 Why?
Tomography, X-Ray Computed
6
2018
2779
0.240
 Why?
Cell Proliferation
8
2019
2543
0.240
 Why?
CD8 Antigens
2
2018
75
0.240
 Why?
Antigens, CD
3
2020
549
0.240
 Why?
Young Adult
13
2020
13992
0.240
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2014
1832
0.230
 Why?
Carcinoma
2
2018
230
0.230
 Why?
National Cancer Institute (U.S.)
1
2025
48
0.230
 Why?
Tumor Cells, Cultured
5
2018
974
0.220
 Why?
Whole-Body Irradiation
2
2016
77
0.220
 Why?
Pilot Projects
5
2019
1839
0.220
 Why?
Brain Neoplasms
4
2018
1305
0.220
 Why?
Socioeconomic Factors
3
2018
1326
0.220
 Why?
DNA Transposable Elements
2
2016
121
0.210
 Why?
T-Lymphocytes, Cytotoxic
2
2015
174
0.210
 Why?
Jaundice, Neonatal
1
2023
8
0.210
 Why?
Longitudinal Studies
5
2016
3011
0.210
 Why?
Sensitivity and Specificity
3
2018
1985
0.210
 Why?
Immunohistochemistry
4
2016
1736
0.200
 Why?
Adolescent
13
2023
22520
0.200
 Why?
Disability Evaluation
3
2014
305
0.200
 Why?
Leukocytes, Mononuclear
3
2015
589
0.200
 Why?
Infant, Very Low Birth Weight
2
2014
72
0.200
 Why?
Protein Engineering
2
2014
111
0.190
 Why?
Problem Behavior
2
2022
104
0.190
 Why?
Proto-Oncogene Proteins
2
2017
626
0.190
 Why?
Parks, Recreational
1
2022
11
0.190
 Why?
Constriction, Pathologic
2
2014
246
0.190
 Why?
Time-to-Treatment
1
2024
231
0.180
 Why?
DNA-Binding Proteins
3
2019
1524
0.180
 Why?
Proteasome Endopeptidase Complex
2
2020
160
0.180
 Why?
HEK293 Cells
5
2017
747
0.180
 Why?
Occupational Therapy
2
2014
109
0.180
 Why?
Burkitt Lymphoma
1
2022
63
0.180
 Why?
Amino Acid Sequence
4
2020
2167
0.180
 Why?
Clone Cells
2
2019
270
0.180
 Why?
Sex Factors
4
2017
2096
0.170
 Why?
Oncogenes
2
2020
120
0.170
 Why?
Biomarkers
3
2019
4242
0.170
 Why?
Adaptation, Psychological
2
2024
687
0.170
 Why?
Exercise Test
2
2015
624
0.170
 Why?
Genes, Tumor Suppressor
2
2019
90
0.170
 Why?
Genes, T-Cell Receptor alpha
1
2021
12
0.170
 Why?
Apyrase
1
2020
24
0.170
 Why?
Gene Expression Regulation
3
2019
2621
0.170
 Why?
Demography
3
2018
297
0.170
 Why?
Cytokines
6
2022
2099
0.170
 Why?
Lectins, C-Type
1
2020
62
0.170
 Why?
HLA Antigens
2
2021
232
0.170
 Why?
Epitope Mapping
2
2018
61
0.170
 Why?
Oncolytic Virotherapy
1
2020
14
0.160
 Why?
MART-1 Antigen
3
2014
11
0.160
 Why?
Pancreatic Neoplasms
2
2022
924
0.160
 Why?
Psychotropic Drugs
1
2021
76
0.160
 Why?
Multiple Myeloma
1
2023
289
0.160
 Why?
Mice, Mutant Strains
1
2020
309
0.160
 Why?
Physical Therapy Modalities
2
2014
325
0.160
 Why?
Models, Immunological
1
2020
101
0.160
 Why?
Lymphatic Metastasis
2
2019
328
0.160
 Why?
Drug Utilization
1
2021
166
0.160
 Why?
HLA-C Antigens
2
2020
38
0.160
 Why?
Metastasectomy
2
2017
20
0.160
 Why?
Protein Binding
8
2020
2265
0.150
 Why?
Remission Induction
5
2020
306
0.150
 Why?
Premature Birth
1
2023
375
0.150
 Why?
Amino Acid Substitution
1
2020
311
0.150
 Why?
Follow-Up Studies
7
2020
5319
0.150
 Why?
Virus Replication
1
2022
544
0.150
 Why?
Gene Regulatory Networks
1
2022
319
0.150
 Why?
Age Factors
3
2024
3330
0.150
 Why?
Genes, Neoplasm
1
2019
24
0.150
 Why?
Neoplasm Recurrence, Local
2
2017
1103
0.150
 Why?
Cysteine
1
2020
212
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2025
929
0.150
 Why?
Alcohol Oxidoreductases
1
2019
63
0.140
 Why?
Neoplasms, Glandular and Epithelial
1
2019
50
0.140
 Why?
Gestational Age
2
2024
973
0.140
 Why?
Prognosis
6
2020
4162
0.140
 Why?
Area Under Curve
3
2014
328
0.140
 Why?
Cell Line
4
2022
2899
0.140
 Why?
Practice Patterns, Physicians'
2
2021
1362
0.140
 Why?
Neoplastic Cells, Circulating
1
2019
80
0.140
 Why?
Trees
1
2018
69
0.140
 Why?
B-Lymphocytes
3
2020
884
0.140
 Why?
Referral and Consultation
4
2023
832
0.140
 Why?
RGS Proteins
1
2018
18
0.140
 Why?
Cohort Studies
6
2016
5897
0.140
 Why?
Behavior Therapy
1
2021
283
0.140
 Why?
Smoking
2
2018
1580
0.140
 Why?
Ubiquitin Thiolesterase
1
2018
61
0.140
 Why?
Education, Special
1
2017
24
0.140
 Why?
Forkhead Transcription Factors
1
2019
203
0.140
 Why?
Mothers
1
2024
784
0.130
 Why?
Medical Oncology
1
2020
332
0.130
 Why?
Psychometrics
2
2019
739
0.130
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2017
3
0.130
 Why?
Parents
4
2022
1457
0.130
 Why?
Hematologic Neoplasms
1
2019
162
0.130
 Why?
Self-Examination
1
2017
2
0.130
 Why?
Uveal Neoplasms
1
2017
17
0.130
 Why?
Recombinant Fusion Proteins
3
2015
678
0.130
 Why?
Societies, Scientific
1
2017
50
0.130
 Why?
Lymphoma, Non-Hodgkin
1
2018
123
0.130
 Why?
Interferon-gamma
5
2020
791
0.130
 Why?
Maternal Age
1
2017
129
0.130
 Why?
Immunologic Surveillance
1
2017
26
0.130
 Why?
Signal Transduction
5
2019
5220
0.130
 Why?
ROC Curve
3
2013
603
0.130
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2017
177
0.130
 Why?
Administration, Intravenous
1
2017
173
0.130
 Why?
Population Surveillance
2
2017
489
0.130
 Why?
fas Receptor
2
2015
94
0.120
 Why?
Tissue and Organ Procurement
1
2020
331
0.120
 Why?
Carcinogenesis
1
2018
233
0.120
 Why?
Sialadenitis
1
2016
2
0.120
 Why?
CTLA-4 Antigen
1
2017
105
0.120
 Why?
Disease Progression
5
2017
2862
0.120
 Why?
WT1 Proteins
1
2016
13
0.120
 Why?
Mitogen-Activated Protein Kinases
1
2017
302
0.120
 Why?
Peptidomimetics
1
2016
4
0.120
 Why?
Logistic Models
4
2016
2108
0.120
 Why?
Green Fluorescent Proteins
2
2015
404
0.120
 Why?
Circulating Tumor DNA
1
2016
38
0.120
 Why?
Antineoplastic Agents
2
2017
2195
0.120
 Why?
HLA-DQ beta-Chains
1
2016
59
0.120
 Why?
Immunoglobulin M
1
2017
288
0.120
 Why?
ras GTPase-Activating Proteins
1
2015
15
0.120
 Why?
Immunoglobulin A
1
2017
218
0.120
 Why?
Urinary Bladder Neoplasms
1
2019
261
0.120
 Why?
Transplantation Chimera
1
2016
57
0.120
 Why?
Immunodominant Epitopes
1
2015
27
0.120
 Why?
Clonal Evolution
1
2016
47
0.120
 Why?
Proto-Oncogene Proteins c-akt
2
2015
441
0.120
 Why?
Coronary Vessels
2
2017
251
0.120
 Why?
Peer Group
1
2018
251
0.120
 Why?
Molecular Targeted Therapy
1
2019
432
0.120
 Why?
Psychoanalytic Therapy
1
1995
14
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2016
135
0.120
 Why?
RNA, Neoplasm
1
2015
83
0.110
 Why?
Receptors, HIV
1
2015
25
0.110
 Why?
Cesarean Section
1
2017
214
0.110
 Why?
Epitopes
2
2015
489
0.110
 Why?
Zinc Fingers
1
2015
54
0.110
 Why?
Aged, 80 and over
3
2025
8077
0.110
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
78
0.110
 Why?
Alphapapillomavirus
1
2015
38
0.110
 Why?
Psychotherapy, Brief
1
1995
41
0.110
 Why?
Odds Ratio
2
2014
1060
0.110
 Why?
Immunophenotyping
1
2016
326
0.110
 Why?
Sarcoma, Synovial
1
2014
22
0.110
 Why?
Neoplasms, Germ Cell and Embryonal
1
2016
78
0.110
 Why?
Immunity, Active
1
2014
9
0.110
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2014
10
0.110
 Why?
Psychotherapy, Group
1
1995
73
0.110
 Why?
Language
1
2018
324
0.110
 Why?
Endoribonucleases
1
2015
79
0.110
 Why?
Metalloproteins
1
2014
6
0.110
 Why?
Managed Care Programs
1
1995
140
0.110
 Why?
Clinical Trials as Topic
5
2020
1044
0.110
 Why?
Aspirin
1
2018
398
0.110
 Why?
Clinical Trials, Phase II as Topic
1
2014
76
0.110
 Why?
Triple Negative Breast Neoplasms
1
2017
206
0.110
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2014
30
0.110
 Why?
5' Untranslated Regions
1
2014
61
0.100
 Why?
Nitric Oxide Synthase Type I
1
2014
30
0.100
 Why?
Thrombotic Microangiopathies
1
2014
20
0.100
 Why?
Echocardiography, Stress
1
2013
24
0.100
 Why?
Ribosomal Proteins
1
2014
93
0.100
 Why?
Tumor Lysis Syndrome
1
2013
8
0.100
 Why?
MAP Kinase Kinase Kinase 5
1
2013
7
0.100
 Why?
Mice, Transgenic
5
2020
2194
0.100
 Why?
Policy Making
1
2014
83
0.100
 Why?
Transcription Factors
2
2019
1754
0.100
 Why?
Autografts
1
2013
51
0.100
 Why?
Thioredoxins
1
2013
32
0.100
 Why?
HLA-DR4 Antigen
1
2013
77
0.100
 Why?
Testis
1
2014
166
0.100
 Why?
Extremities
1
2014
141
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1135
0.100
 Why?
Motor Skills
1
2014
105
0.100
 Why?
Health Care Reform
1
2014
109
0.100
 Why?
Psychiatric Status Rating Scales
1
2015
553
0.100
 Why?
Cross-Sectional Studies
5
2017
5760
0.100
 Why?
Gene Expression Regulation, Enzymologic
1
2014
273
0.100
 Why?
Immunoglobulin G
1
2017
898
0.100
 Why?
Interferon-alpha
1
2014
197
0.100
 Why?
Transcriptional Activation
1
2015
380
0.100
 Why?
Astrocytoma
1
2013
130
0.100
 Why?
Allografts
1
2013
151
0.100
 Why?
Histones
1
2018
669
0.090
 Why?
Likelihood Functions
1
2013
145
0.090
 Why?
Cell Movement
4
2019
973
0.090
 Why?
Radiation Injuries
1
2014
150
0.090
 Why?
Nanotechnology
1
2013
126
0.090
 Why?
Nuclear Proteins
2
2015
759
0.090
 Why?
Cognition
2
2023
1271
0.090
 Why?
Receptors, N-Methyl-D-Aspartate
1
2014
227
0.090
 Why?
Survival Rate
4
2020
2008
0.090
 Why?
Infant, Newborn
4
2023
6382
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
245
0.090
 Why?
Esophageal Neoplasms
1
2016
345
0.090
 Why?
Risk Factors
5
2023
10661
0.090
 Why?
Calcinosis
1
2014
238
0.090
 Why?
Sarcoma
1
2014
194
0.090
 Why?
Muscle Proteins
1
2013
243
0.090
 Why?
Cost of Illness
1
2014
319
0.090
 Why?
Risk Assessment
3
2019
3582
0.090
 Why?
Propensity Score
1
2013
350
0.090
 Why?
Killer Cells, Natural
1
2014
475
0.090
 Why?
Prostatic Neoplasms
1
2019
1058
0.080
 Why?
Research Design
2
2014
1124
0.080
 Why?
Genome, Human
1
2013
429
0.080
 Why?
Head and Neck Neoplasms
1
2016
563
0.080
 Why?
Anxiety
1
2018
1091
0.080
 Why?
Health Policy
1
2014
395
0.080
 Why?
Cytotoxicity, Immunologic
3
2016
222
0.080
 Why?
Randomized Controlled Trials as Topic
2
2013
1674
0.080
 Why?
Xenograft Model Antitumor Assays
3
2020
942
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2014
994
0.080
 Why?
Genetic Testing
1
2013
474
0.080
 Why?
RNA-Binding Proteins
1
2014
464
0.080
 Why?
Wounds and Injuries
1
2018
945
0.080
 Why?
Decision Support Techniques
1
2013
445
0.080
 Why?
Models, Theoretical
1
2013
588
0.070
 Why?
K562 Cells
2
2020
95
0.070
 Why?
Time Factors
2
2017
7039
0.070
 Why?
HIV-1
1
2015
892
0.070
 Why?
Real-Time Polymerase Chain Reaction
3
2015
346
0.070
 Why?
Databases, Factual
3
2023
1465
0.070
 Why?
Adenocarcinoma
1
2016
912
0.070
 Why?
Coronary Stenosis
1
2008
38
0.070
 Why?
Colorado
2
2017
4668
0.070
 Why?
RNA
1
2015
933
0.070
 Why?
Comorbidity
3
2018
1681
0.070
 Why?
Protein Kinase Inhibitors
1
2014
965
0.070
 Why?
Arthritis, Rheumatoid
1
2017
1219
0.070
 Why?
Double-Blind Method
1
2013
2021
0.070
 Why?
Apoptosis
2
2013
2519
0.070
 Why?
Anti-HIV Agents
1
2015
861
0.070
 Why?
Neoplasm Transplantation
3
2015
253
0.060
 Why?
RNA, Small Interfering
3
2014
637
0.060
 Why?
Neutrophils
1
2013
1134
0.060
 Why?
Protective Factors
2
2017
98
0.060
 Why?
Faculty
1
2007
153
0.060
 Why?
Cross Reactions
2
2016
134
0.060
 Why?
DNA Mutational Analysis
2
2019
404
0.060
 Why?
Mass Screening
2
2020
1336
0.060
 Why?
Molecular Sequence Data
3
2015
2944
0.060
 Why?
Cardiovascular Diseases
1
2018
2114
0.060
 Why?
CD4 Antigens
2
2016
146
0.060
 Why?
Neutropenia
2
2017
152
0.060
 Why?
Mice, Inbred NOD
2
2018
611
0.060
 Why?
Mice, Inbred C57BL
4
2020
6055
0.050
 Why?
Single-Chain Antibodies
2
2015
18
0.050
 Why?
Protein Transport
2
2017
447
0.050
 Why?
Retrospective Studies
5
2024
16781
0.050
 Why?
Intercellular Junctions
2
2014
38
0.050
 Why?
Physical Examination
2
2017
245
0.050
 Why?
Parity
1
2024
110
0.050
 Why?
GPI-Linked Proteins
2
2014
78
0.050
 Why?
Nerve Tissue Proteins
2
2020
607
0.050
 Why?
Lung
1
2016
4108
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2023
27
0.050
 Why?
Point Mutation
2
2014
243
0.050
 Why?
Exercise
1
2015
2165
0.050
 Why?
Health Facilities
1
2023
84
0.050
 Why?
Autoantigens
2
2016
427
0.050
 Why?
Bone Marrow
1
2023
301
0.050
 Why?
Minority Groups
1
2024
279
0.050
 Why?
Receptors, Cell Surface
1
2004
379
0.050
 Why?
Cluster Analysis
2
2014
526
0.040
 Why?
Linear Models
1
2024
860
0.040
 Why?
Alleles
2
2015
893
0.040
 Why?
Skin
2
2019
774
0.040
 Why?
Oligonucleotide Array Sequence Analysis
2
2014
763
0.040
 Why?
Educational Status
1
2023
464
0.040
 Why?
Severity of Illness Index
2
2023
2938
0.040
 Why?
Recombinant Proteins
2
2014
1372
0.040
 Why?
Proportional Hazards Models
1
2024
1294
0.040
 Why?
Models, Genetic
2
2013
593
0.040
 Why?
Jurkat Cells
1
2020
118
0.040
 Why?
Parenting
1
2024
326
0.040
 Why?
Base Sequence
2
2014
2200
0.040
 Why?
Predictive Value of Tests
2
2017
2087
0.040
 Why?
Immunoglobulins
1
2020
162
0.040
 Why?
Cysteine Endopeptidases
1
2020
74
0.040
 Why?
Glioma
1
2004
428
0.040
 Why?
Early Diagnosis
1
2020
247
0.040
 Why?
Health Care Surveys
1
2021
565
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
90
0.040
 Why?
Hydrolysis
1
2019
199
0.040
 Why?
Fusion Regulatory Protein 1, Heavy Chain
1
2018
3
0.040
 Why?
GTP Phosphohydrolases
1
2019
96
0.040
 Why?
Caregivers
2
2018
971
0.040
 Why?
Uterine Cervical Dysplasia
1
2018
30
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gi-Go
1
2018
17
0.030
 Why?
Forests
1
2018
60
0.030
 Why?
Protein Domains
1
2020
308
0.030
 Why?
Cervix Uteri
1
2018
51
0.030
 Why?
Nuclear Localization Signals
1
2017
18
0.030
 Why?
Neoplasm Grading
1
2019
312
0.030
 Why?
Mice, SCID
1
2018
373
0.030
 Why?
Disulfides
1
2018
99
0.030
 Why?
Hydrogen Bonding
1
2018
169
0.030
 Why?
Healthcare Disparities
1
2024
692
0.030
 Why?
Platelet Aggregation
1
2018
102
0.030
 Why?
Ligands
2
2013
670
0.030
 Why?
Human papillomavirus 18
1
2017
14
0.030
 Why?
Eye Enucleation
1
2017
15
0.030
 Why?
Response Evaluation Criteria in Solid Tumors
1
2017
21
0.030
 Why?
Protein Stability
1
2018
175
0.030
 Why?
GTP-Binding Protein alpha Subunits
1
2017
16
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gq-G11
1
2017
20
0.030
 Why?
Culture Media, Serum-Free
1
2016
45
0.030
 Why?
Peptide Fragments
2
2015
702
0.030
 Why?
Lymphopenia
1
2017
68
0.030
 Why?
Binding Sites
1
2020
1329
0.030
 Why?
Drug Synergism
1
2017
370
0.030
 Why?
Vaccinia virus
1
2016
44
0.030
 Why?
Antigen-Presenting Cells
1
2017
163
0.030
 Why?
HLA-DRB1 Chains
1
2017
111
0.030
 Why?
Adenosine Triphosphate
1
2019
488
0.030
 Why?
Asymptomatic Diseases
1
2017
98
0.030
 Why?
Blood Chemical Analysis
1
2017
110
0.030
 Why?
Salivary Glands, Minor
1
2016
11
0.030
 Why?
Tissue Array Analysis
1
2016
51
0.030
 Why?
Health Surveys
1
2018
512
0.030
 Why?
Cell Membrane
1
2020
709
0.030
 Why?
Leukemia, B-Cell
1
2016
13
0.030
 Why?
Neoplasm Invasiveness
1
2018
520
0.030
 Why?
Radiotherapy
1
2017
206
0.030
 Why?
HLA-A1 Antigen
1
2015
4
0.030
 Why?
Fas Ligand Protein
1
2015
60
0.030
 Why?
Antigen-Antibody Reactions
1
2015
50
0.030
 Why?
Palate
1
2016
40
0.030
 Why?
Genes, erbB-2
1
2015
32
0.030
 Why?
MAP Kinase Signaling System
1
2017
325
0.030
 Why?
Anemia
1
2017
178
0.030
 Why?
Interferon-gamma Release Tests
1
2015
33
0.030
 Why?
Salvage Therapy
1
2016
159
0.030
 Why?
Anus Neoplasms
1
2015
33
0.030
 Why?
Feasibility Studies
1
2020
1051
0.030
 Why?
Health Promotion
1
2022
764
0.030
 Why?
Compulsive Behavior
1
2015
9
0.030
 Why?
Machine Learning
1
2021
574
0.030
 Why?
Gastrointestinal Diseases
1
2017
211
0.030
 Why?
Cloning, Molecular
1
2016
538
0.030
 Why?
Thrombocytopenia
1
2017
209
0.030
 Why?
DNA, Neoplasm
1
2015
162
0.030
 Why?
HIV Envelope Protein gp120
1
2015
61
0.030
 Why?
Coronary Occlusion
1
2015
20
0.030
 Why?
Necrosis
1
2016
248
0.030
 Why?
Dermatitis
1
2014
20
0.030
 Why?
HIV Antibodies
1
2015
66
0.030
 Why?
Income
1
2016
198
0.030
 Why?
Regression Analysis
1
2017
1013
0.030
 Why?
Metabolic Clearance Rate
1
2014
117
0.030
 Why?
Protein Conformation
1
2018
941
0.030
 Why?
Desmoplakins
1
2014
27
0.030
 Why?
Transplantation, Homologous
1
2016
414
0.030
 Why?
Monophenol Monooxygenase
1
2014
8
0.030
 Why?
Comparative Genomic Hybridization
1
2014
30
0.030
 Why?
Cell Survival
1
2017
1136
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
154
0.030
 Why?
Nausea
1
2014
112
0.030
 Why?
Mice, Inbred BALB C
1
2017
1272
0.030
 Why?
Gene Library
1
2014
123
0.030
 Why?
Models, Statistical
1
2018
686
0.030
 Why?
Random Allocation
1
2014
370
0.030
 Why?
National Institutes of Health (U.S.)
1
2014
136
0.030
 Why?
MAP Kinase Kinase 4
1
2013
23
0.030
 Why?
Social Class
1
2016
273
0.030
 Why?
Histocompatibility Antigens
1
2014
108
0.030
 Why?
Substrate Specificity
1
2014
383
0.030
 Why?
Infusions, Intravenous
1
2014
423
0.030
 Why?
Graft vs Host Disease
1
2016
262
0.030
 Why?
Lentivirus
1
2013
60
0.020
 Why?
X-Ray Diffraction
1
2013
105
0.020
 Why?
Tumor Burden
1
2014
319
0.020
 Why?
Confidence Intervals
1
2014
332
0.020
 Why?
Radiotherapy, Adjuvant
1
2014
217
0.020
 Why?
Immunoenzyme Techniques
1
2013
206
0.020
 Why?
Immunoprecipitation
1
2013
153
0.020
 Why?
Fever
1
2014
311
0.020
 Why?
Sleep Wake Disorders
1
2017
320
0.020
 Why?
Structure-Activity Relationship
1
2014
577
0.020
 Why?
Bias
1
2013
208
0.020
 Why?
Drug Administration Schedule
1
2014
774
0.020
 Why?
Reproducibility of Results
2
2012
3381
0.020
 Why?
Health Services Accessibility
1
2021
1061
0.020
 Why?
Cotinine
1
2012
78
0.020
 Why?
Models, Molecular
1
2018
1624
0.020
 Why?
Histocompatibility Antigens Class II
1
2014
367
0.020
 Why?
DNA Primers
1
2013
518
0.020
 Why?
Cost-Benefit Analysis
1
1995
624
0.020
 Why?
Receptors, Immunologic
1
2013
207
0.020
 Why?
Spleen
1
2014
517
0.020
 Why?
Bayes Theorem
1
2013
427
0.020
 Why?
Blotting, Western
1
2013
1223
0.020
 Why?
Pregnancy
1
2023
7164
0.020
 Why?
Diagnosis, Differential
1
2015
1505
0.020
 Why?
Liver Neoplasms
1
2017
757
0.020
 Why?
Multivariate Analysis
1
2014
1511
0.020
 Why?
Carrier Proteins
1
2014
752
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
2057
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2015
1228
0.020
 Why?
Kinetics
1
2013
1628
0.020
 Why?
Phosphorylation
1
2014
1781
0.020
 Why?
Infant, Premature
1
2014
610
0.020
 Why?
North Carolina
1
2008
128
0.020
 Why?
Germany
1
2008
139
0.020
 Why?
Self Report
1
2012
878
0.020
 Why?
Cell Differentiation
1
2015
2023
0.020
 Why?
Disease Models, Animal
1
2018
4538
0.020
 Why?
Vaccination
1
2016
1483
0.020
 Why?
MicroRNAs
1
2013
698
0.020
 Why?
Models, Biological
1
2014
1831
0.020
 Why?
Intelligence
1
2007
135
0.020
 Why?
Polymorphism, Single Nucleotide
1
2013
2181
0.010
 Why?
Receptors, Urokinase Plasminogen Activator
1
2004
15
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2004
30
0.010
 Why?
Transplantation, Heterologous
1
2004
197
0.010
 Why?
Species Specificity
1
2004
577
0.010
 Why?
Neovascularization, Pathologic
1
2004
295
0.010
 Why?
Mice, Nude
1
2004
710
0.010
 Why?
Down Syndrome
1
1987
515
0.010
 Why?
Polyethylene Glycols
1
2004
642
0.010
 Why?
Endothelium, Vascular
1
2004
962
0.010
 Why?
Rosenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (595) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)